Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2022-11-14 | 2023-02-02 | 174604 |
TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2022-12-22 | 2023-04-28 | 179297 |
TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-21 | 190686 |
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2023-06-08 | 2023-06-27 | 194097 |
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2023-06-16 | 2023-06-27 | 195201 |
TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-07-23 | 2020-08-21 | 120887 |
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2020-08-20 | 2020-10-08 | 122705 |
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2020-09-24 | 2020-10-08 | 124989 |
TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-11-06 | 2020-11-12 | 128019 |
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2024-08-08 | 2024-11-01 | 234882 |
TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2024-09-05 | 2024-11-01 | 236808 |
TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2021-01-07 | 2021-02-18 | 131075 |
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-01-07 | 2021-02-25 | 131084 |
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-02-18 | 2021-03-04 | 134337 |
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-03-11 | 2021-03-25 | 135567 |
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-03-11 | 2021-03-18 | 135570 |
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-10-07 | 2021-11-11 | 146853 |
TEVA-RAMIPRIL | 5MG | CAPSULE | Actual shortage | 2025-03-13 | 2025-04-24 | 252578 |
TEVA-RAMIPRIL | 10MG | CAPSULE | Actual shortage | 2025-03-13 | 2025-05-08 | 252581 |
TEVA-RAMIPRIL | 2.5MG | CAPSULE | Actual shortage | 2025-05-02 | 2025-05-02 | 256450 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 |